Association between COVID-19 and adverse pregnancy outcomes in Cape Town: A retrospective study

Résumé

Background: Adverse pregnancy outcomes significantly contribute to maternal morbidity and mortality. Despite substantial global evidence, data on the effects of coronavirus disease 2019 (COVID-19) on maternal and neonatal outcomes in South Africa remain limited. Aim: To investigate the association between COVID-19 and adverse pregnancy outcomes. Setting: Tygerberg Hospital, Cape Town, South Africa. Methods: We performed a retrospective analysis of pregnant women tested for COVID-19 (categorised as positive or negative), admitted to Tygerberg Hospital between 01 March 2020 and 31 March 2021. The primary outcome was a composite of stillbirth, preterm birth, neonatal death, low birth weight, and maternal death. Binary logistic regression models were used to evaluate predictors of adverse pregnancy outcomes. Variables with p < 0.1 in the univariate model, along with clinically relevant covariates (maternal age, parity, COVID-19, human immunodeficiency virus [HIV], and preeclampsia), were included in the final multivariable model. Statistical analyses were performed via Stata/SE® (version 17.0) at α = 0.05. Results: Of 350 pregnant women (mean age: 29.8 years, [standard deviation {s.d.}: 6.99]), majority were in the third trimester (77.4%) and nulliparous (51.4%). Adverse outcomes occurred in 167 (47.7%) participants, with a higher prevalence among those without COVID-19 (51.4% vs. 43.6%) and those with preeclampsia (68.3% vs. 33.3%) compared to their counterparts. Preeclampsia was significantly associated with a higher risk of adverse pregnancy outcomes (adjusted odds ratio [AOR]: 2.87; 95% confidence interval [CI]: 1.62–5.09), whereas COVID-19 was not (AOR: 0.79; 95% CI: 0.42–1.46). Conclusion: COVID-19 was not associated with increased risk of adverse pregnancy outcomes. Conversely, preeclampsia significantly predicted adverse outcomes. Contribution: These findings underscore the importance of targeted antenatal interventions to mitigate maternal and neonatal morbidity during future pandemics.

Citer ce document

Accès au document

Texte intégral en lecture en ligne, réservé aux abonnés SPHAERO et aux membres de l'institution. Se connecter

Auteur(s)

Statistiques

Consultations : 1

Téléchargements : 0